Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2026-01-01 @ 12:44 PM
Study NCT ID:
NCT05141357
Status:
TERMINATED
Last Update Posted:
2025-12-24
First Post:
2021-11-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer
Sponsor:
HUYABIO International, LLC.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-15
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-04-19
Completion Date Type:
ACTUAL
First Submit Date:
2021-11-19
First Submit QC Date:
None
Study First Post Date:
2021-12-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-09-04
Results First Submit QC Date:
None
Results First Post Date:
2025-12-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-23
Last Update Post Date:
2025-12-24
Last Update Post Date Type:
ACTUAL